Search Results - "Meares, Diane"
-
1
Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity
Published in Nature communications (14-07-2023)“…Hemophilia A is the most common X-linked bleeding disorder affecting more than half-a-million individuals worldwide. Persons with severe hemophilia A have…”
Get full text
Journal Article -
2
Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII
Published in Frontiers in immunology (15-12-2022)“…Placenta-derived mesenchymal cells (PLCs) endogenously produce FVIII, which makes them ideally suited for cell-based fVIII gene delivery. We have previously…”
Get full text
Journal Article -
3
Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A
Published in Molecular therapy. Methods & clinical development (12-06-2020)“…The delivery of factor VIII (FVIII) through gene and/or cellular platforms has emerged as a promising hemophilia A treatment. Herein, we investigated the…”
Get full text
Journal Article -
4
Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A
Published in Frontiers in cell and developmental biology (10-08-2021)“…Patients with the severe form of hemophilia A (HA) present with a severe phenotype, and can suffer from life-threatening, spontaneous hemorrhaging. While…”
Get full text
Journal Article -
5
Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia A
Published in Frontiers in bioengineering and biotechnology (01-03-2021)“…Microfluidic technology enables recapitulation of organ-level physiology to answer pertinent questions regarding biological systems that otherwise would remain…”
Get full text
Journal Article -
6
In Utero Transplantation of FVIII-Expressing Human Placental Cells Upregulates Gene Pathways Associated with Immune Tolerance, Altering the Response to Postnatal FVIII Infusion
Published in Blood (23-11-2021)“…We have previously reported that in utero transplantation (IUTx) of sheep fetuses (n=14) with human placental cells (PLC) transduced with a lentiviral vector…”
Get full text
Journal Article -
7
Administration of Cells Engineered to Secrete Fviii-mcoET3 in Prenatal Sheep Recipients Results in Sustained Curative Fviii Plasma Levels for 3 Years after Birth, without Immune or Toxicity-Related Adverse Events
Published in Blood (05-11-2020)“…The treatment of hemophilia A (HA) patients by prenatal transplantation (PNT) is a feasible, yet underestimated and unexplored clinical approach. The…”
Get full text
Journal Article -
8
Delivery of Fviii-mcoET3 to Previously Untreated Sheep Using Human Placental Cells Enables Durable Elevation of Plasma FVIII Levels and Avoids Inhibitor Formation
Published in Blood (05-11-2020)“…Hemophilia A (HA) is characterized by a decrease in the functional clotting protein factor VIII (FVIII). Current hemophilia treatments consist of either…”
Get full text
Journal Article -
9
Prenatal Transplantation of Placental Cells Engineered to Express FVIII Leads to Corrective Plasma Levels of FVIII after Birth
Published in Blood (08-12-2017)“…Prenatal transplantation (PNTx) is a clinically viable procedure that has been performed in ~50 human patients for 14 different genetic disorders. When…”
Get full text
Journal Article